UAE COVID vaccine trial rolls out with 5000 volunteers

▴ uae-covid-vaccine-trial-news-update
UAE Coronavirus News Updates Aug 10, 2020

The world’s first Phase III trials of an inactivated vaccine for COVID-19 being held in the United Arab Emirates have reached a major milestone with over 5000 volunteers who have now received their first vaccination.

The 5000th vaccination was given in the presence of Dr. Jamal Al Kaabi, the Acting Undersecretary Department of Health, Abu Dhabi, at the recently developed purpose-built walk-in registration, screening and testing centre at the Abu Dhabi National Exhibition Centre (ADNEC). Dr. Al Kaabi was the second participant in the vaccination programme and received his second shot this week.

The trials began in Abu Dhabi on 16th July and are being managed by G42 Healthcare in partnership with the Department of Health - Abu Dhabi, the UAE Ministry of Health and Prevention (MOHAP) and Abu Dhabi Health Services Company (SEHA).

The inactivated vaccine has been developed by Sinopharm CNBG, the world’s sixth-largest vaccine manufacturer.

A sense of national pride and shared commitment has led to over 80 nationalities in the community already volunteering to participate, inspired by the UAE Leadership’s commitment to overcoming the pandemic through a global collaborative effort.

The ADNEC facility can manage 1000 volunteers a day and is open daily from 8 am to 8 pm to allow the maximum number of individuals to participate. A second walk-in centre is also now operational at the Al Qarain Health Centre in Sharjah with a daily capacity of 500.

The Ministry of Health and Prevention, MoHAP, announced Sunday that it conducted 61,544 additional COVID-19 tests over the past 24 hours, using state-of-the-art medical testing equipment. In a statement, the Ministry stressed its aim to continue expanding the scope of testing nationwide to facilitate the early detection of coronavirus cases and carry out the necessary treatment. To control the pandemic, anyone showing symptoms of COVID-19 at university in Dubai must be isolated instantly and referred for a PCR test, the newly released ‘Protocols for the Reopening of Higher Education Institutions [HEI] in Dubai’ said on Monday.

The 118-point protocol, announced by Dubai’s Knowledge and Human Development Authority (KHDA), said such a person “should not return to HEI until the result is obtained. Even if the result is negative and there is a clinical assessment of a probable COVID-19 case, the person should commence a 14-day quarantine.”

As part of its intensified testing campaign, MoHAP announced 225 new coronavirus cases, bringing the total number of cases in the UAE to 62,525. According to the Ministry, the infected individuals are from various nationalities, are in a stable condition, and are receiving the necessary care.

MoHAP also announced one death due to COVID-19 complications, bringing the total number of deaths in the country to 357.

The Ministry expressed its sincere condolences to the family of the deceased and wished current COVID-19 patients a speedy and full recovery, calling on all members of the society to cooperate with health authorities, adhere to the instructions and social distance to ensure the health and safety of all. MoHAP also noted an additional 323 individuals had fully recovered from COVID-19, bringing the total number of recoveries to 56,568.

Tags : #UAECovidNewsUpdateAug10 #Dubai #ADNECFacility #SinopharmCNBG #MoHap #AbuDhabi

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024
Why the World Trusts Indian Pharmaceuticals for Life-Saving SolutionsDecember 20, 2024
International Tsunami Conference Concludes at AmritapuriDecember 20, 2024
Prestige Marks 75 Years of Revolutionizing Home Cooking with Iconic Innovative ProductsDecember 20, 2024